As the market’s leading independent healthcare equity research provider, we strive to separate market noise from the insights that are essential to the investment process.
Nephron’s primary differentiators lie in our research teams and their approach to equity research. The deep experience and insight of our analysts as well as an intense drive to serve a discerning client base sets us apart. With the sole focus of creating value for clients, Nephron can provide a depth of coverage, breadth of access, and consultative services that traditional models lack.
Delivered via an independent and unbiased subscription-only model, Nephron is directly aligned with our client’s interests and investment processesMeet The Team
At Nephron Research, our experience and connectivity drive deep research products which is supplemented by hyper-relevant corporate access
We tackle the most important debates, react quickly, and provide leading perspective
NEPHRON RESEARCH COVID-19 Daily Tracker: June 3, 2020; Hot Spots - StatesDownload
HMOs and Hospitals: 20 Questions and 20 Answers to Quantify the COVID19 ImpactDownload
A Closer Look: COVID-19 Script Declines Represent an Acute, Not Chronic, ProblemDownload
Nephron Research Curates Dozens of Events Each Year Designed for Maximum Impact to Client Investment Process
The 2023 Nephron PBM Innovation Symposium will focus on challenges to the traditional PBM model with equal attention given to political pressures from Congress and the FTC alongside competitive pressures from alternative PBM and specialty models.
Josh Raskin and team believe that the next era of healthcare will be defined by the trend of physician enablement whereby companies will be able to benefit from the value created through risk based contracts. Josh will host his second symposium assembling a full day of panels with thought leaders and expert practitioners to dissect and discuss this emerging segment of healthcare.
The second annual LBx Symposium where Jack Meehan will host both public and private companies alongside experts in the field.
Our independent model and deep healthcare and investment expertise allows us to deliver a full suite of bespoke
and consultative services to investment firms and market participants.